Daicel Corporation, a Japanese enterprise founded in Osaka in 1919, conducts its business operations across Japan, Asia, North America, and Europe. The company is a key producer and distributor of a broad array of products, including cellulosic derivatives, organic chemicals, diverse plastics, and pyrotechnic devices. Its extensive activities are organized into distinct segments: Medical/Healthcare, Smart, Safety, Materials, Engineering Plastics, and other specialized areas. In the Medical/Healthcare sector, Daicel supplies various cosmetic components such as 1,3-Butylene glycol, polyglycerin, and thickeners, in addition to natural health food ingredients and dietary supplements. For the pharmaceutical industry, it provides specialized chiral and achiral columns, a variety of chiral and bio reagents, and DNA/RNA-based probes, supported by comprehensive analytical, purification, synthesis, formulation, and specialized analytical tool services. The "Smart" segment focuses on advanced materials for the electronics industry, offering triacetylcellulose and films for display technologies, solvents for electronic applications, polymers for resist processes, and cleaning agents for semiconductors. Moreover, Daicel contributes to visualization technologies with its optical components, lens units, silver nanoparticle inks, and organic semiconductor devices. Within the Safety domain, the company manufactures inflators for vehicle airbags and pyro-fuses, alongside safety mechanisms for non-automotive products. Daicel is also a significant supplier of foundational chemicals and raw materials, including acetic acid and its derivatives, cellulose acetate, and acetate tow for resins, inks, and paint solvents. It further develops specialty chemicals such as cycloaliphatic epoxies, caprolactone, ketene derivatives, and alkylamines, which are vital for electrical materials and coatings. For the Engineering Plastics segment, Daicel delivers a wide selection of plastic solutions, encompassing engineering plastics, plastic compound products, functional sheets, molded trays, and packaging films. Beyond these core offerings, the company also produces water treatment systems and diffusers tailored for diverse industrial requirements. Daicel's comprehensive portfolio plays a crucial role in various sectors, including transportation, electronics, medical care, personal care, daily life, and environmental and energy applications. The company, which was initially named Daicel Chemical Industries, Ltd., officially adopted its current name, Daicel Corporation, in October 2011.
最新資料
¥1,476
+¥23.00 · +1.58%
盤中時間採用JST。市場資料可能有所延遲。
Daicel Corporation, a Japanese enterprise founded in Osaka in 1919, conducts its business operations across Japan, Asia, North America, and Europe. The company is a key producer and distributor of a broad array of products, including cellulosic derivatives, organic chemicals, diverse plastics, and pyrotechnic devices. Its extensive activities are organized into distinct segments: Medical/Healthcare, Smart, Safety, Materials, Engineering Plastics, and other specialized areas. In the Medical/Healthcare sector, Daicel supplies various cosmetic components such as 1,3-Butylene glycol, polyglycerin, and thickeners, in addition to natural health food ingredients and dietary supplements. For the pharmaceutical industry, it provides specialized chiral and achiral columns, a variety of chiral and bio reagents, and DNA/RNA-based probes, supported by comprehensive analytical, purification, synthesis, formulation, and specialized analytical tool services. The "Smart" segment focuses on advanced materials for the electronics industry, offering triacetylcellulose and films for display technologies, solvents for electronic applications, polymers for resist processes, and cleaning agents for semiconductors. Moreover, Daicel contributes to visualization technologies with its optical components, lens units, silver nanoparticle inks, and organic semiconductor devices. Within the Safety domain, the company manufactures inflators for vehicle airbags and pyro-fuses, alongside safety mechanisms for non-automotive products. Daicel is also a significant supplier of foundational chemicals and raw materials, including acetic acid and its derivatives, cellulose acetate, and acetate tow for resins, inks, and paint solvents. It further develops specialty chemicals such as cycloaliphatic epoxies, caprolactone, ketene derivatives, and alkylamines, which are vital for electrical materials and coatings. For the Engineering Plastics segment, Daicel delivers a wide selection of plastic solutions, encompassing engineering plastics, plastic compound products, functional sheets, molded trays, and packaging films. Beyond these core offerings, the company also produces water treatment systems and diffusers tailored for diverse industrial requirements. Daicel's comprehensive portfolio plays a crucial role in various sectors, including transportation, electronics, medical care, personal care, daily life, and environmental and energy applications. The company, which was initially named Daicel Chemical Industries, Ltd., officially adopted its current name, Daicel Corporation, in October 2011.
日內區間
目前¥1,476
52週區間
目前¥1,476
盤中時間採用JST。市場資料可能有所延遲。
Daicel Corporation, a Japanese enterprise founded in Osaka in 1919, conducts its business operations across Japan, Asia, North America, and Europe. The company is a key producer and distributor of a broad array of products, including cellulosic derivatives, organic chemicals, diverse plastics, and pyrotechnic devices. Its extensive activities are organized into distinct segments: Medical/Healthcare, Smart, Safety, Materials, Engineering Plastics, and other specialized areas. In the Medical/Healthcare sector, Daicel supplies various cosmetic components such as 1,3-Butylene glycol, polyglycerin, and thickeners, in addition to natural health food ingredients and dietary supplements. For the pharmaceutical industry, it provides specialized chiral and achiral columns, a variety of chiral and bio reagents, and DNA/RNA-based probes, supported by comprehensive analytical, purification, synthesis, formulation, and specialized analytical tool services. The "Smart" segment focuses on advanced materials for the electronics industry, offering triacetylcellulose and films for display technologies, solvents for electronic applications, polymers for resist processes, and cleaning agents for semiconductors. Moreover, Daicel contributes to visualization technologies with its optical components, lens units, silver nanoparticle inks, and organic semiconductor devices. Within the Safety domain, the company manufactures inflators for vehicle airbags and pyro-fuses, alongside safety mechanisms for non-automotive products. Daicel is also a significant supplier of foundational chemicals and raw materials, including acetic acid and its derivatives, cellulose acetate, and acetate tow for resins, inks, and paint solvents. It further develops specialty chemicals such as cycloaliphatic epoxies, caprolactone, ketene derivatives, and alkylamines, which are vital for electrical materials and coatings. For the Engineering Plastics segment, Daicel delivers a wide selection of plastic solutions, encompassing engineering plastics, plastic compound products, functional sheets, molded trays, and packaging films. Beyond these core offerings, the company also produces water treatment systems and diffusers tailored for diverse industrial requirements. Daicel's comprehensive portfolio plays a crucial role in various sectors, including transportation, electronics, medical care, personal care, daily life, and environmental and energy applications. The company, which was initially named Daicel Chemical Industries, Ltd., officially adopted its current name, Daicel Corporation, in October 2011.
日內區間
目前¥1,476
52週區間
目前¥1,476
近期已公布業績
近期已公布業績
年度分割調整後的每股現金分配。
¥60.00
2025年(完整年度)+87.5% 自從 2021
2026年(部分年度):¥65.00
¥32.00
2,021
¥36.00
2,022
¥45.00
2,023
¥55.00
2,024
¥60.00
2,025
¥65.00
2,026*
* 在現有股息歷史記錄中,該日曆年僅包含部分期間。
| 行動 | 除息日 | 詳情 | 記錄日期 | 付款日期 |
|---|---|---|---|---|
股息即將實施 | 2027年3月30日 | ¥35.00Semi-Annual | 2027年3月31日 | 2027年3月30日 |
股息 | 2026年9月29日 | ¥35.00Semi-Annual | 2026年9月30日 | 2026年9月29日 |
股息 | 2026年3月30日 | ¥30.00Semi-Annual | 2026年3月31日 | 2026年6月22日 |
股息 | 2025年9月29日 | ¥30.00Semi-Annual | 2025年9月30日 | 2025年12月2日 |
股息 | 2025年3月28日 | ¥30.00Semi-Annual | 2025年3月31日 | 2025年6月23日 |
股息 | 2024年9月27日 | ¥30.00Semi-Annual | 2024年9月30日 | 2024年12月3日 |
除息 2027年3月30日
¥35.00
Semi-Annual
2027年3月31日登記 · 支付日 2027年3月30日
除息 2026年9月29日
¥35.00
Semi-Annual
2026年9月30日登記 · 支付日 2026年9月29日
除息 2026年3月30日
¥30.00
Semi-Annual
2026年3月31日登記 · 支付日 2026年6月22日
除息 2025年9月29日
¥30.00
Semi-Annual
2025年9月30日登記 · 支付日 2025年12月2日
除息 2025年3月28日
¥30.00
Semi-Annual
2025年3月31日登記 · 支付日 2025年6月23日
除息 2024年9月27日
¥30.00
Semi-Annual
2024年9月30日登記 · 支付日 2024年12月3日
報告持有此股票曝險的交易所交易基金。
NEXT FUNDS TOPIX Exchange Traded Fund1306.T91.23億0.03%35.17兆 JPY0.05%¥431.3-0.28%
NEXT FUNDS JPX-Nikkei Index 400 Exchange Traded Fund1591.T9.11億0.04%2.37兆 JPY0.11%¥37,180+0.08%
iShares Core TOPIX ETF1475.T8.04億0.03%3.01兆 JPY0.05%¥425-0.21%
iShares JPX-Nikkei 400 ETF1364.T2.45億0.04%6176.33億 JPY0.05%¥3,822-0.08%
Avantis International Small Cap Value ETFAVDV5069.35萬0.25%200.82億 USD0.36%US$108.58+0.51%
Vanguard Total International Stock ETFVXUS3314.19萬0.00%6657億 USD0.05%US$84.54+0.12%
Vanguard FTSE Developed Markets ETFVEA2023.07萬0.01%3238億 USD0.03%US$70.06+0.16%
iShares Core MSCI EAFE ETFIEFA1601萬0.01%1889.44億 USD0.07%US$96.64+0.48%
NEXT FUNDS TOPIX Exchange Traded Fund1306.T
NEXT FUNDS JPX-Nikkei Index 400 Exchange Traded Fund1591.T
iShares Core TOPIX ETF1475.T
iShares JPX-Nikkei 400 ETF1364.T
Avantis International Small Cap Value ETFAVDV
Vanguard Total International Stock ETFVXUS
Vanguard FTSE Developed Markets ETFVEA
iShares Core MSCI EAFE ETFIEFAAI 生成內容及延遲市場資料僅供資訊與教育用途,不構成投資建議。